Our #1 Biotech stock for September

This email is an advertisement from a third party and not necessarily an endorsement by Option Sensei. Always perform your own due diligence. Dear Friend, Can you imagine doubling your money in one morning? It's happened 3 times in the past 6 months with takeovers. On May 4th, 2020, investors made 154% in one morning - when Stemline Therapeutics was taken over. On March 4, 2020, investors made 147% in one morning - when Forty-Seven was taken over by Gilead. And on December 9, 2019 investors made 100% in one morning - when Arqule was taken over by Merck. [Here's the next biotech we think gets taken over ]( Big Pharma bought each of these companies because of their new cancer treatments. And takeover master Dylan Jovine has just released the next biotech he thinks gets taken over. This tiny biotech recently signed a deal with Bristol-Myers - because of their powerful new cancer treatment. Dylan Jovine is an expert when it comes to picking biotech takeovers: On August 19, 2019, investors made 144% in one morning - when Array Biopharma was taken over by Pfizer. On October 1st of 2018, investors made 91% in one morning - when Tesaro was taken over by Glaxo. On January 4th, 2019, investors made 71% in one morning - when Loxo Oncology was taken over by Eli Lilly. [Get the next biotech he think gets taken over ]( Sincerely, Brad Sullivan Publisher Behind the Markets   NOTE: If URLs do not appear as live links in your e-mail program, please cut and paste the full URL into the location or address field of your browser. [Click here to unsubscribe]( Copyright © 2021 Mesh Publishing. All rights reserved. 146 W 29th St, Rm 8E, New York, NY 10001